Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Kumar

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
FEBS Letters|April 7, 1997
Essential role of Rac GTPase in hydrogen peroxide-induced activation of c-fos serum response elementJ H Kim, H J Kwack, S E Choi, et al.
Molecular and Cellular Biology|June 25, 1998
Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformationH He, T Watanabe, X Zhan, et al.
Cancer Research|November 1, 1995
SCH 51344 inhibits ras transformation by a novel mechanismC C Kumar, C Prorock-Rogers, J Kelly, et al.
Cancer Research|March 31, 2001
Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonistC C Kumar, M Malkowski, Z Yin, et al.
Advances in Experimental Medicine and Biology|August 19, 2000
Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesisC C Kumar, L Armstrong, Z Yin, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
FEBS Letters|April 7, 1997
Essential role of Rac GTPase in hydrogen peroxide-induced activation of c-fos serum response elementJ H Kim, H J Kwack, S E Choi, et al.
Molecular and Cellular Biology|June 25, 1998
Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformationH He, T Watanabe, X Zhan, et al.
Cancer Research|November 1, 1995
SCH 51344 inhibits ras transformation by a novel mechanismC C Kumar, C Prorock-Rogers, J Kelly, et al.
Cancer Research|March 31, 2001
Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonistC C Kumar, M Malkowski, Z Yin, et al.
Advances in Experimental Medicine and Biology|August 19, 2000
Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesisC C Kumar, L Armstrong, Z Yin, et al.
Pageof 4